Risk factor
Very poor trading liquidity
Profitability factor
Very favourable analyst view
About
Shalby Limited is a prominent healthcare organization primarily managing a network of multi-specialty hospitals across India. The company delivers an extensive spectrum of medical services, including advanced orthopedic care such as hip and knee joint replacements, arthroscopy, and arthroplasty, alongside comprehensive cardiology and cardiothoracic and vascular surgery. Its diverse offerings also encompass cosmetic and aesthetic procedures, dental implantology, emergency medicine, endocrinology, various forms of endoscopy and laparoscopy, ENT surgery, gastroentero surgery, gastroenterology, and general medical and surgical treatments. Further specialized services provided by Shalby include hair transplantation, liver disease and transplant management, infectious disease treatment, infertility and IVF solutions, intensive and critical care, maxillofacial surgery, nephrology, neurosurgery, neurology, obesity surgery, obstetrics and gynecology, oncology and oncosurgery, ophthalmology and glaucoma, pediatric orthopedics, pathology and microbiology, pediatrics and neonatology, plastic surgery, pulmonology and chest medicine, radiology and imaging, rheumatology, trauma care, organ donation, and urosurgery. The company operates 11 hospitals with a combined bed capacity of 2,012 and extends its reach through 50 outpatient clinics. Beyond direct patient care, Shalby is involved in medical education, offering programs and fellowships for paramedical students and other healthcare professionals. It also provides home-based healthcare services, covering attendants, doctors, nursing, physiotherapy, pathology, pharmacy, and medical equipment, and conducts clinical research trials. While its primary operations are in India, Shalby Limited also maintains an international presence in countries such such as Kenya, Tanzania, Rwanda, Uganda, the United Arab Emirates, Bangladesh, Cambodia, Jakarta, Oman, Uzbekistan, and Nepal. Established in 1994, the company was initially known as Shalby Hospitals Limited before adopting its current name in February 2008, and its headquarters are located in Ahmedabad, India.
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITD.
Target Price
The average target price of SHALBY.NS is 310 and suggests 87% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in